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The terminal N-Boc protected diamino PAMAM 7 was condensed (EDC-DMAP) with two units of mycophenolic acid (MPA)
giving the N-Boc protected dendron 8 in a good yield (76%). The ammonium trifluoroacetate 9 was prepared from 8 by acid
treatment (TFA-THF-H
2
O) and was split into two equal parts. The first half was treated with di-2-pyridyl thionocarbonate (DPT)
in the presence of Et
3
N to give the corresponding isothiocyanate 10. This was reacted with the second half of 9 providing the
symmetrical dendrimer 11 (68% yield), exposing four MPA units around the thioureido-PAMAM core.
1. Introduction
Mycophenolic acid (MPA, 1) is a potent inhibitor of inosine
monophosphate dehydrogenase (IMPDH), a key enzyme
in the de novo synthesis of guanine nucleotide [1]. MPA
exhibits antiproliferation activity and has been established as
an anticancer agent, an immunosuppressant [1, 2] as well as
an antiviral drug against some plant viruses [3–5]. Among
these promising properties of MPA, the immunosuppressant
property is by far the most important. MPA is a cornerstone
immunosuppressant used to prevent rejection after organ
transplantation. Currently, two MPA derivatives are used
clinically for this purpose (Figure 1): mycophenolate sodium
(MPS, Myfortic, 2) and mycophenolate mofetil (MMF, Cell-
Cept, 3). Several structural modification ofMPAwere carried
out during the last twenty years to advance the elucidation of
the structure-activity relationship of MPA in its interaction
with IMPDH and contributed to the understanding of the
relevant sites required for drug activity. Analogues which
displayed similar or better immunosuppressive activity were
reported. These derivatives present modifications only at the
terminal carboxylic acid [6–11].
In the search of new immunosuppressants, we planned
the preparation of a new family of MPA derivatives linking
more units of MPA to a scaffold by means of the carboxylic
group. Among the possible scaffolds, we decided to use
dendrimers as a drug delivery system (4, Figure 1) [12].
These are nanostructured macromolecules characterized by
a tree-like architecture with exponential numbers of discrete
dendritic branches radiating out from a common core. One
of the most commonly known dendrimeric structure is the
poly(amidoamine) (PAMAM) dendrimer which was intro-
duced and developed by Tomalia and Fre´chet [13]. PAMAM
dendrimers aremonodispersed, biocompatible, and synthetic
macromolecules with well-defined structural architecture
and composition. Here, we present the synthesis of PAMAM
derivatives decorated with MPA units. The antiviral activity
of these compounds has been recently tested in Nicotiana
tabacum L. cv. Xanthi explants infected with a cucumber
mosaic virus [14].
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Figure 1: Mycophenolic acid (1) and its marketed derivatives (2) and (3); schematic representation of the structure of a generic dendrimer
(4) and of a single PAMAM branch (4a).
2. Experimental
Melting points were determined with a Kofler hot-stage
apparatus and are uncorrected. Optical rotations were mea-
sured with a Perkin-Elmer 241 polarimeter at 20 ± 2∘C. 1H
NMR and 13C NMR spectra were recorded in appropriate
solvents with a Bruker Avance II spectrometer operating at
250.12MHz (1H) and 62.9MHz (13C). Spin resonances were
reported as chemical shifts (𝛿) in part per million (ppm) and
the references to the residual peak of the solvent employed
as follows: CD
3
CN 1.94 ppm (1H NMR, central band) and
1.28 ppm (13C NMR, central band), CD
3
OD 3.31 ppm (1H
NMR, central band) and 49.0 ppm (13C NMR, central band).
Spin multiplicity was indicated by s = singlet, d = doublet, t =
triplet, bt = broad triplet, q = quartet,m=multiplet. Coupling
constants 𝐽 were reported in Hertz (Hz). The assignments
were made, when possible, with the aid of DEPT, HETCOR,
COSY, and HSQC experiments. Low resolution mass spec-
tra were recorded on a LCQ Advantage ThermoFinnigan
spectrometer equipped with an ion trap analyzer (Thermo
Electron Company, San Jose, CA, USA). All reactions were
followed by TLC on Kieselgel 60 F
254
with detection by UV
light and/or with ethanolic 10% phosphomolybdic or sulfuric
acid andheating. Kieselgel 60 (E.Merck, 70–230 and 230–400
mesh, resp.) was used for column and flash chromatography.
Solvents were dried and purified by distillation according to
standard procedure [15] and stored over 4 A˚ molecular sieves
activated for at least 24 h at 200∘C. MgSO
4
was used as the
drying agent for solutions. Compounds 5 and7were prepared
according to the reported procedures [16].
2.1. Synthesis of Compound 6. A solution of mycophenolic
acid (1) (125mg, 0.390mmol, 1.2 eq) and amine 5 (57mg,
0.354mmol) in dry DMF (1.5mL) containing Et
3
N (148𝜇L,
1.06mmol, 3.0 eq) was treated at room temperature with
1-ethyl-3-(3-(dimethylamino)-propyl)-carbodiimide hydro-
chloride (EDC, 90.4mg, 0.472mmol, 1.34 eq) and N-
hydroxybenzotriazole (HOBt, 49.2mg, 0.364mmol, 1.03 eq).
The solution was stirred at room temperature until TLC
analysis (9 : 1 CH
2
Cl
2
-MeOH, 21 h) revealed the complete dis-
appearance of amine 5 and the formation of a major product
(𝑅
𝑓
= 0.85).Themixture was concentrated under diminished
pressure and the purification of the residue by flash chro-
matography over silica gel (2 : 8 hexane-EtOAc) gave pure
6 (120mg, 73% calculated from 5) as a solid foam; 𝑅
𝑓
=
0.22 (2 : 8 hexane-EtOAc); 1H NMR (250.12MHz, CD
3
CN-
CDCl
3
): 𝛿 1.38 [s, 9H, C(CH3)3], 1.92 (s, 3H, =CCH3), 2.10 (s,
3H, Ar-CH3), 2.18–2.24 (m, 4H, =C(CH2)2CO), 2.98 (q, 2H, 𝐽
= 5.7Hz,CH2NHCO), 3.10 (q, 2H, 𝐽 = 5.7Hz,CH2NHCOO),
3.34 (d, 2H, 𝐽 = 7.0Hz, ArCH2CH=), 3.73 (s, 3H, CH3),
5.20 (s, 2H, ArCH2OCO), 5.17 (t, 1H, 𝐽 = 7.0Hz, CH=C),
5.42 (bt, 1H, NHCO), 6.53 (bt, 1H, NHCOO), 7.74 (s, 1H,
OH); 13C NMR (62.9MHz, CD
3
CN-CDCl
3
): 𝛿 11.6 (Ar-
CH3), 16.3 (=CCH3), 23.1 (ArCH2CH=), 28.5 [C(CH3)3],
35.4, 35.8 (=C(CH2)2CO), 40.0, 40.9 [HN(CH2)2NH], 61.5
(OCH3), 70.8 (ArCH2O), 79.3 [C(CH3)3], 107.2 (C=), 123.3
(CH=), 116.0, 122.5, 135.3, 145.8 (4 × Ar-C), 157.0 (O-C=O),
153.8, 164.2 (2 × Ar-C-O), 173.2, 173.6 (2 × C=O). ESIMS:
calcd for C
24
H
34
N
2
O
7
Na [M+Na]+ 485.5, found 485.3. Anal.
Calcd for C
24
H
34
N
2
O
7
: C, 62.32; H, 7.41; N, 6.06. Found: C,
62.34; H, 7.44; N, 6.08.
2.2. Synthesis of Compound 8
Method A (EDC, HOBT, Et3N, and DMF). A solution of
mycophenolic acid (1) (369mg, 1.151mmol, 1.2 eq) and amine
7 (204mg, 0.525mmol) in dry DMF (6.0mL) containing
Et
3
N (48𝜇L, 3.48mmol, 3.0 eq) was treated at room tem-
perature with EDC (296mg, 0.514mmol, 1.33 eq) and HOBt
(161mg, 1.19mmol, 1.03 eq) and the solution was stirred at
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room temp. After 48 h, TLC analysis (8 : 2 CH
2
Cl
2
-MeOH)
revealed the complete disappearance of amine 7 and the
formation of a major product (𝑅
𝑓
= 0.71). The mixture was
concentrated under diminished pressure and the purification
of the residue by flash chromatography over silica gel (88 : 12
CH
2
Cl
2
-MeOH) gave pure 8 (298mg, 57% calculated from
7).
Method B (EDC, DMAP, and DMF). A solution of amine 7
(98.4mg, 0.253mmol) and mycophenolic acid (1) (179mg,
0.558mmol, 2.2 eq) in dryDMF (3mL)was treatedwith EDC
(130mg, 0.676mmol, 2.67 eq) and 4-dimethylaminopyridine
(DMAP, 9.3mg, 0.0759mmol, 0.3 eq). The mixture was
stirred at room temperature and after 48 h the TLC analysis
(9 : 1 CH
2
Cl
2
-MeOH) revealed the complete disappearance of
amine 7 and the formation of a major product (𝑅
𝑓
= 0.40).
The mixture was concentrated under diminished pressure
and the purification of the residue by flash chromatography
over silica gel (CH
2
Cl
2
-MeOH 92 : 8) gave pure 8 (191mg,
76%).
Compound 8 was a solid foam; 𝑅
𝑓
= 0.12 (92 : 8
CH
2
Cl
2
-MeOH); 1H NMR (250.12MHz, CD
3
OD-CDCl
3
):
𝛿 1.40 [s, 9H, C(CH3)3], 1.80 (s, 6H, 2 × =CCH3), 2.13
(s, 6H, 2 × Ar-CH3), 2.30 (bt, 4H, 𝐽 = 6.3Hz, 2 ×
NCH
2
CH2CONH), 2.32 (bs, 8H, 2 × =C(CH2)2CO),
2.50 (t, 2H, 𝐽 = 6.8Hz, NCH2CH2NHCOO), 2.75 (bt,
4H, 𝐽 = 6.3Hz, 2 × NCH2CH2CONH), 3.15 (t, 2H,
𝐽 = 6.8Hz, NCH
2
CH2NHCOO), 3.30 [m, 8H, 2 ×
CONH(CH2)2NHCO], 3.36 (d, 4H, 𝐽 = 6.6Hz, 2 ×
ArCH2CH=), 3.75 (s, 6H, 2 × OCH3), 5.41 (m, 6H, 2 ×
CH=C, 2 × ArCH2OCO); 13C NMR (62.9MHz, CD3OD-
CDCl
3
): 𝛿 11.6 (2 × ArCH3), 23.5 (2 × ArCH2CH=), 16.3 (2 ×
=CCH3), 33.4 (2 × NCH2CH2CONH), 28.7 [C(CH3)3], 35.6,
36.3 (2 × =C(CH2)2CO), 39.8, 39.7 [2 × HN(CH2)2NH], 38.4
(NCH
2
CH2NHCOO), 50.8 (2 × NCH2CH2CONH), 53.1
(NCH2CH2NHCOO), 61.5 (2 × OCH3), 70.7 (2 × ArCH2O),
80.1 [C(CH
3
)
3
], 107.5 (2 × C=), 123.9 (2 × CH=), 117.7, 123.3,
134.8, 145.8 (8 × Ar-C), 158.1 (O-C=O), 154.5, 164.6 (4 ×
Ar-C-O), 173.6, 174.3, 175.6 (6 × C=O). ESIMS: calcd for
C
51
H
72
N
2
O
14
Na [M + Na]+ 1015.5, found 1015.4. Anal. Calcd
for C
51
H
72
N
6
O
14
: C, 61.68; H, 7.31; N, 8.46. Found: C, 61.70;
H, 7.33; N, 8.47.
2.3. Synthesis of Dendrimer 11. A solution of 8 (186mg,
0.186mmol) in CH
2
Cl
2
-TFA-H
2
O 7.4 : 2.4 : 0.2 (2.0mL) was
stirred at room temperature until the TLC analysis (8 : 2
CH
2
Cl
2
-MeOH, 1 h) revealed the complete disappearance
of the starting material and the formation of a major
product (𝑅
𝑓
= 0.36). The reaction mixture was concentrated
under diminished pressure and repeatedly coevaporated with
toluene (4 × 30mL). The crude residue (184mg) analyzed
by NMR proved to be constituted only by the ammonium
trifluoroacetate 9. The salt 9 is a solid foam, 𝑅
𝑓
= 0.36 (8 : 2
CH
2
Cl
2
-MeOH); 1H NMR (250.12MHz, CD
3
CN): 𝛿 1.77 (s,
6H, 2 × =CCH3), 2.10 (s, 6H, 2 × Ar-CH3), 2.70 (bs, 4H, 2 ×
NCH2CH2CONH), 2.18–2.30 (m, 12H, 2 × =C(CH2)2CO, 2 ×
NCH
2
CH2CONH), 3.05 (m, 2H, NCH2CH2NH3+), 3.32 (d,
4H, 𝐽 = 6.8Hz, 2 × ArCH2CH=), 3.20, 3.40 [2m, each 4H,
2 × CONH(CH2)2NHCO], 3.44 (m, 2H, CH2NH3+), 3.72 (s,
6H, 2 × OCH3), 5.16 (m, 6H, 2 × CH=C, 2 × ArCH2OCO),
10.1 (bs, 4H, 4 × NHCO), 7.80 (s, 2H, 2 × OH); 13C NMR
(62.9MHz, CD
3
CN): 𝛿 11.6 (2 × Ar-CH3), 16.2 (2 × =CCH3),
23.3 (2×ArCH2CH=), 29.1 (2×NCH2CH2CONH), 35.9, 36.4
(2 × =C(CH2)2CO), 38.7, 39.9 [2 × HN(CH2)2NH], 51.9 (2 ×
NCH2CH2CONH), 36.4 (CH2NHCO), 50.1 (CH2NH3+),
61.6 (2 × OCH3), 71.0 (2 × ArCH2O), 123.8 (2 × CH=), 107.3
(2 × C=), 119.0, 122.7, 135.2, 146.2 (8 × Ar-C), 153.9, 164.3 (4 ×
Ar-CO), 173.0, 176.0, 173.4 (6 × C=O).
To a solution of crude 9 (92mg, 0.0912mmol) in dry
CH
2
Cl
2
(1.4mL), Et
3
N (100 𝜇L) and 2-pyridyl thiocarbonate
(DPT, 22mg, 0.0912mmol) were added at room temperature.
After 6 h the TLC analysis (7 : 3 EtOAc-iprOH) revealed
the complete disappearance of the starting material and the
formation of a major product (𝑅
𝑓
= 0.24). The solution
was concentrated under diminished pressure and the crude
isothiocyanate intermediate 10 (86mg, 0.0912mmol) was
solubilized in dry 1 : 1 CH
2
Cl
2
-DMF (1.0mL) and a solution
of crude 9 (92mg, 0.0912mmol) in dry 1 : 1 CH
2
Cl
2
-DMF
(2.0mL) containing Et
3
N (0.2mL) was added dropwise.
The reaction mixture was stirred at room temperature for
43 h, until TLC analysis (7 : 3 EtOAc-iprOH) revealed the
formation of a major product at 𝑅
𝑓
= 0.22. The reaction
was concentrated at reduced pressure and the crude was
subjected to a flash chromatography (EtOAc) on silica gel to
give dendrimer 11 (114mg, 68% from 9) as a foam solid; 𝑅
𝑓
=
0.22 (7 : 3 EtOAc-iprOH); 1H NMR (250.12MHz, CD
3
OD-
CDCl
3
): 𝛿 1.81 (s, 12H, 4 × =CCH3), 2.14 (s, 12H, 4 ×
Ar-CH3), 2.26 [bs, 16H, 4 × =C(CH2)2CO], 2.34 (bt, 8H,
𝐽 = 6.4Hz, 4 × NCH
2
CH2CONH), 2.72–2.86 (m, 12H, 2 ×
NCH2CH2NHCS, 4 × NCH2CH2CONH), 3.22 [m, 16H,
4 × CONH(CH2)2NHCO], 3.37 (d, 8H, 𝐽 = 7.0Hz, 4 ×
ArCH2CH=), 3.58 (t, 4H, 𝐽 = 5.6Hz, NCH2CH2NHCS), 3.76
(s, 12H, 4 ×OCH3), 5.21 (s, 8H, 4 ×ArCH2OCO), 5.24 (t, 4H,
𝐽 = 7.3Hz, 4×CH=C); 13CNMR (62.9MHz, CD
3
CN-D
2
O): 𝛿
11.5 (4 × Ar-CH3). 16.3 (4 × =CCH3), 23.5 (4 × ArCH2CH=),
34.8 (4 × NCH
2
CH2CONH), 35.8, 36.4 [4 × =C(CH2)2CO],
39.9 [4 × HN(CH2)2NH], 44.3 (NCH2CH2NHCS), 50.8 (4 ×
NCH2CH2CONH), 54.2 (2 × NCH2CH2NHCS), 61.5 (4 ×
OCH3), 70.7 (4 × ArCH2O), 107.5 (4 × C=), 117.6, 123.4, 134.9,
146.2 (16 × Ar-C), 124.3 (4 × CH=), 154.5, 164.5 (8 × Ar-C-
O), 173.6, 174.7, 175.7 (12 × C=O), 179.8 (C=S). ESIMS: calcd
for C
93
H
126
N
12
O
24
SNa [M +Na]+ 1849.9, found 1849.7. Anal.
Calcd for C
93
H
126
N
12
O
24
S: C, 61.10; H, 6.95; N, 9.19. Found:
C, 61.13; H, 6.98; N, 9.21.
3. Results and Discussion
Derivative 6 was first prepared, as a positive control for
biological evaluations (Scheme 1). The monoprotected N-
Boc-ethylenediamine 5 [16], which is also used as the central
core in the construction of PAMAM dendrons, was used
as capping reagent. The same kind of additional functional
groups will be present in all synthetic structures, thus ensur-
ing similar interactions during the evaluation of immunosup-
pressant properties.
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Scheme 2: Synthesis of compound 8. Reaction conditions: EDC, DMPA, DMF, room temperature, 48 h (76% yield) or EDC, HOBt, DMF,
Et
3
N, room temperature, 48 h (57% yield).
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC),
which is nowadays preferred to N,N󸀠-dicyclohexylcarbodi-
imide (DCC) in the formation of amide bonds because it is
not a skin sensitizer and its urea by-product can be easily
removed, was chosen as a coupling agent and the reaction
was carried out at room temperature in the presence of
N-hydroxybenzotriazole (HOBt) and triethylamine (Et
3
N).
Compound 6 was isolated after 12 h in a 73% yield after
flash chromatography on silica gel. The two-branched struc-
ture 7 [16] was easily obtained via double Michael addi-
tion of methyl acrylate to N-Boc-ethylenediamine followed
by amidation of the intermediate with a large excess of
ethylenediamine.This was then reacted with 1 using the same
coupling conditions seen above (Scheme 2). The reaction
required longer time (48 h) to go to completion and afforded
8 in a poor 57% yield. Better results were obtained when
N,N-dimethylaminopyridine (DMAP) was used instead of
the mixture Et
3
N-HOBt. In this case, the desired com-
pound was isolated in a 76% yield after chromatographic
purification.
Having obtained this structure, the synthesis of the
symmetrical dendrimer 11 was possible (Scheme 3). First,
the acid labile N-Boc protecting group was removed (tri-
fluoroacetic acid-water, in CH
2
Cl
2
) giving the ammonium
trifluoroacetate salt 9 in a quantitative yield. The structure
and purity of 9 were confirmed by NMR analysis, which
verified the complete removal of the t-butoxy carbonyl group.
The latter compound was then reacted, without purification,
with di-2-pyridyl thionocarbonate (DPT) and triethylamine.
DPT [17, 18] is a commercially available, solid, nontoxic
reagent that can be used in the preparation of isothiocyanates
as a safe alternative to thiophosgene. The reaction proceeded
smoothly and gave the complete conversion after 5.5 h.
The intermediate isothiocyanate obtained after removal of the
solvents was directly reacted with crude 9 in the presence of
Et
3
N in a mixture of CH
2
Cl
2
and DMF.
Dendrimer 11 was obtained after flash chromatographic
purification in a satisfactory 68% overall yield. The sym-
metrical structure of compound 11 and the formation of
the thioureido bridge (diagnostic C=S signal) were fully
confirmed by 1H, 13C and 2D NMR experiments.
4. Conclusions
In conclusion, we reported the synthesis of poly (ami-
doamine) structures decorated with mycophenolic acid. The
target structures were prepared in good overall yields and
with a limited number of purification steps. Furthermore,
the very same strategy could be used to prepare dendrimers
of higher generation. On the other hand, the presence of
the orthogonally protected amino group on the inner core
could allow for the preparation of a library of asymmetrical
structures coupling the dendron with different compounds
rather than its symmetrical counterpart. The immunosup-
pressant properties of these compounds are currently under
investigation and the results will be published in due course.
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